Downregulation of PD-L1 expression by Wnt pathway inhibition to enhance PD-1 blockade efficacy in hepatocellular carcinoma

被引：0
|
作者：
Yu-Yun Shao [1 ]
Han-Yu Wang [3 ]
Hung-Wei Hsu [4 ]
Rita Robin Wo [3 ]
Ann-Lii Cheng [3 ]
Chih-Hung Hsu [3 ]
机构：
[1] National Taiwan University College of Medicine,Graduate Institute of Oncology
[2] National Taiwan University College of Medicine,Department of Internal Medicine
[3] National Taiwan University Hospital,Department of Oncology
[4] National Taiwan University Cancer Center,Department of Medical Oncology
来源：
Biology Direct | / 20卷 / 1期
关键词：
Beta-catenin; Hepatocellular carcinoma; Immunotherapy; Programmed death-ligand 1; Tankyrase; Wnt pathway;
D O I：
10.1186/s13062-025-00645-8
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
    Bai, Jie
    Gao, Zhitao
    Li, Xiang
    Dong, Liang
    Han, Weidong
    Nie, Jing
    ONCOTARGET, 2017, 8 (66) : 110693 - 110707
  • [2] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade
    Lin, Heng
    Wei, Shuang
    Vatan, Linda
    Kryczek, Ilona
    Zou, Weiping
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [3] PD-L1/PD-1 In Hepatocellular Carcinoma: An Institutional Review
    Poveda, Julio
    Duarte, Melissa
    Jones, Patricia Denise
    Chowdhury, Aneesa
    Brown, Kevin
    Garcia-Buitrago, Monica
    LABORATORY INVESTIGATION, 2019, 99
  • [4] PD-L1/PD-1 In Hepatocellular Carcinoma: An Institutional Review
    Poveda, Julio
    Duarte, Melissa
    Jones, Patricia Denise
    Chowdhury, Aneesa
    Brown, Kevin
    Garcia-Buitrago, Monica
    MODERN PATHOLOGY, 2019, 32
  • [5] Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade
    Lipson, Evan J.
    Lilo, Mohammed T.
    Ogurtsova, Aleksandra
    Esandrio, Jessica
    Xu, Haiying
    Brothers, Patricia
    Schollenberger, Megan
    Sharfman, William H.
    Taube, Janis M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [6] Efficacy of PD-1/PD-L1 blockade monotherapy in clinical trials
    Zhao, Bin
    Zhao, Hong
    Zhao, Jiaxin
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [7] INTRATUMORAL EXPRESSION OF PD-1/PD-L1 IMMUNE CHECKPOINT IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Baquerizo, Angeles
    Vavinskaya, Vera
    Rojas, Angela
    Mhoyan, Anna
    Romero-Gomez, Manuel
    Sher, Linda
    Madani, Bahar
    Fisher, Jonathan
    Schaffer, Randolph
    Frenette, Catherine T.
    Marsh, Christopher
    HEPATOLOGY, 2019, 70 : 206A - 206A
  • [8] Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
    Saito, Hiroaki
    Kono, Yusuke
    Murakami, Yuki
    Shishido, Yuji
    Kuroda, Hirohiko
    Matsunaga, Tomoyuki
    Fukumoto, Yoji
    Osaki, Tomohiro
    Ashida, Keigo
    Fujiwara, Yoshiyuki
    ANTICANCER RESEARCH, 2018, 38 (01) : 107 - 112
  • [9] PD-L1 Expression in Mucosal Malignant Melanoma: Implications for PD-1/PD-L1 Blockade Therapy
    Lilo, Mohammed
    Berry, Sneha
    Xu, Haiying
    Ogurtsova, Aleksandra
    Lipson, Evan
    Taube, Janis
    MODERN PATHOLOGY, 2015, 28 : 123A - 123A
  • [10] PD-L1 Expression in Mucosal Malignant Melanoma: Implications for PD-1/PD-L1 Blockade Therapy
    Lilo, Mohammed
    Berry, Sneha
    Xu, Haiying
    Ogurtsova, Aleksandra
    Lipson, Evan
    Taube, Janis
    LABORATORY INVESTIGATION, 2015, 95 : 123A - 123A
12345